.jpg)
.png)
(1).png)
Features
April 16, 2025
National Lipid Association Releases Expert Clinical Review on Familial Chylomicronemia Syndrome (FCS)
The National Lipid Association (NLA) has released a comprehensive clinical review titled “Familial Chylomicronemia...
Read More...April 10, 2025
National Lipid Association and American Geriatrics Society Release Joint Clinical Consensus on Managing Hypercholesterolemia in Older Adults Without History of Atherosclerotic Cardiovascular Disease
Read More...March 28, 2025
NLA and ASPC Release Joint Expert Consensus on Chylomicronemia Management
The National Lipid Association (NLA), in collaboration with the American Society for Preventive Cardiology (ASPC), has...
Read More...December 20, 2024
Ionis Receives FDA Approval for TRYNGOLZA (Olezarsen) for Adults with FCS
On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to...
Read More...November 22, 2024
Call for NLA Board Nominations is Open!
Call for Nominations is open for the National Lipid Association Board of Directors and Chapter officers and will...
Read More...